Indian Pharma Network – Buy prescriptions drugs

Pentasa (Mesalamine)

  • Medicine Name: Pentasa
  • API: Mesalamine
  • Dosage Form & Strength: Extended-release capsules: 250 mg and 500 mg
  • Manufactured By: Takeda Pharms USA

Medical Uses

Pentasa (mesalamine) is an aminosalicylate used for the induction of remission and the treatment of mildly to moderately active ulcerative colitis in adult patients.

Recommended Dosage: The recommended dosage for the induction of remission and the symptomatic treatment of mildly to moderately active ulcerative colitis in adults is 1 g (4 Pentasa 250 mg capsules or 2 Pentasa 500 mg capsules) administered orally 4 times daily.
Swallow capsules whole; do not crush or chew. Alternatively, the oral capsule(s) may be opened and the entire contents sprinkled onto applesauce or yogurt. Consume the entire mixture immediately. Drink an adequate amount of fluids during treatment.

Warning & Precautions

  • Treatment with Mesalamine 250 mg/500 mg should be used with great caution for patients with either chronic kidney disease or reduced kidney function. Additionally, chronic use may lead to complications that require preventative measures. Thus, regular kidney functionality tests should be conducted.
  • Some patients experience abdominal pain along with cramping, diarrhea, and even fever. If any of these symptoms worsen after introducing Mesalamine to the treatment plan, the dose should be discontinued as it poses the danger of increasing severity to the point of a medical emergency.
  • In extreme cases, there exists the possibility of rashes, struggling to breathe, or swelling up that sensitive individuals may get. For those that are salicylate allergy positive, mesalamine must be avoided completely. More so, hypersensitivity reactions after ingestion require immediate medical attention.
  • Patients with pre-existing liver complications should use mesalamine with caution, as it may be responsible for causing liver toxicity and abnormal liver function tests. Monitor liver enzymes regularly to detect early signs of hepatic failure or liver damage.
  • Stevens-Johnson syndrome and toxic epidermal necrolysis are two very severe skin disorders that occur in patients using mesalamine, albeit infrequently but require prompt intervention. Such symptoms of discontinuation of medication include rashes that leave behind blisters and peeling skin.
  • Concurrent use of mesalamine 250 mg/500 mg increases the likelihood of severe sunburns or skin rashes due to heightened photosensitivity. Patients must take care to cover themselves properly avoid long periods of sun exposure and apply broad-spectrum sunscreen while on this medication.
  • The use of mesalamine increases the likelihood of the development of kidney stones. Patients should maintain a proper level of hydration and fluid intake, particularly those with a history of nephrolithiasis or urinary tract issues, to decrease the likelihood of developing stones.
  • Mesalamine can cross the placental barrier, therefore it should only be used during pregnancy if needed. Its effects on fetal development are not fully understood. Consult your healthcare provider to evaluate risks versus benefits before use.
  • Nursing infants could potentially suffer from diarrhea as mesalamine and its active metabolites are excreted in breast milk. A healthcare provider should be consulted by breastfeeding mothers before breastfeeding while taking mesalamine to properly evaluate risks versus benefits.

Documentation & Availability

What documents are required to import PENTASA to India?

PENTASA (mesalamine) capsules can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:

  • A valid prescription from a qualified doctor.
  • Patients diagnostic reports
  • Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

  • A valid prescription from the Doctor
  • Import permit if applicable

Is PENTASA available in India?

PENTASA (mesalamine capsules) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

  • On availability of Pentasa in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  • On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait,
  • Iraq, Saudi Arabia, and the UAE).
  • Medicine Price.
  • Finding Genuine and reliable sources from the USA, Canada,
  • Europe, and Australia
  • Ensuring 100% transparency.

PENTASA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of PENTASA (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Pentasa 250 mg/500 mg price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Sourcing & Delivery

Indian Pharma Network can source PPENTASA (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

FDA

What is the Generic Name for the trade name drug Pentasa®?

Mesalamine is a Generic Name for the trade name drug Pentasa®.

What is the Manufacturer's Name of Pentasa®?

Pentasa® is manufactured by Takeda Pharms USA.

Is Pentasa® approved by the FDA?

Yes, Pentasa® is approved by the FDA. Date of first approval: May 10, 1993.

What is the dosage and form of Pentasa® supplied?

Pentasa is supplied as extended-release capsules: 250 mg and 500 mg for oral administration.

What are the most common side effects of Pentasa® capsules?

The most common side effects of Pentasa® are nausea and vomiting

How much does Pentasa® 250 mg/500 mg capsules cost in India?

Prices of Pentasa 250 mg/500 mg may fluctuate over time because of market dynamics and regulatory changes. To get the most recent Pentasa 250 mg/500 mg capsules cost in India, please Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Pentasa® 250 mg/500 mg capsules be available in SAARC countries?

Apart from Gulf countries, Pentasa® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Pentasa® capsules in these countries. We help ensure legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Pentasa® 250 mg/500 mg capsules online in India?

Yes, one can buy Pentasa 250 mg/500 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Pentasa® oral capsules through legal channels.

What are the storage conditions of Pentasa® capsules?

Store extended-release capsules at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F). Keep the capsules in the original container, protected from light.

Contact Patient Support

If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.

Product Enquiry